Screening and Treatment of Dyslipidemias in Children and AdolescentsDaniels S.R.
Department of Pediatrics, University of Colorado, Denver School of Medicine, Aurora, Colo., USA
Background/Aims: Cardiovascular disease is the most prominent cause of mortality worldwide. A key risk factor for atherosclerotic cardiovascular disease is the presence of dyslipidemia. Clinical approaches to evaluation and treatment of dyslipidemia in children and adolescents are presented. Methods: A review of published guidelines and presentation of illustrative cases. Results: Dyslipidemia is an important risk factor in early-stage atherosclerosis. Children and adolescents at high risk for dyslipidemia can be identified using a positive family history or the presence of other risk factors as a trigger. Once high-risk individuals are identified, primary treatment is lifestyle modification. In cases where low-density lipoprotein-cholesterol is high, pharmacologic intervention may be needed. Conclusions: Screening of appropriate children and adolescents for dyslipidemia and treating those at high risk are important for the long-term prevention of cardiovascular disease.
Stephen R. Daniels, MD, PhD
Department of Pediatrics, University of Colorado, Denver School of Medicine
13123 East 16th Avenue, B065
Aurora, CO 80045 (USA)
Tel. +1 720 777 2766, E-Mail firstname.lastname@example.org
Published online: July 21, 2011
Number of Print Pages : 5
Number of Figures : 0, Number of Tables : 2, Number of References : 13
Hormone Research in Paediatrics (From Developmental Endocrinology to Clinical Research)
Vol. 76, No. Suppl. 1, Year 2011 (Cover Date: July 2011)
Journal Editor: Czernichow P. (Paris)
ISSN: 1663-2818 (Print), eISSN: 1663-2826 (Online)
For additional information: http://www.karger.com/HRP